TRAF3IP3
TRAF3-interacting JNK-activating modulator
Also known as: T3JAM, T3JAM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y228
- Gene
- TRAF3IP3
- Ensembl
- ENSG00000009790
- Chromosome
- 1
- Canonical length
- 551 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The gene encodes a protein that mediates cell growth by modulating the c-Jun N-terminal kinase signal transduction pathway. The encoded protein may also interact with a large multi-protein assembly containing the phosphatase 2A catalytic subunit. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
Canonical amino-acid sequenceUniProt
551 residues, UniProt reviewed canonical sequence.
>Q9Y228|TRAF3IP3
1 MISPDPRPSP GLARWAESYE AKCERRQEIR ESRRCRPNVT TCRQVGKTLR IQQREQLQRA
61 RLQQFFRRRN LELEEKGKAQ HPQAREQGPS RRPGQVTVLK EPLSCARRIS SPREQVTGTS
121 SEVFPAQHPP PSGICRDLSD HLSSQAGGLP PQDTPIKKPP KHHRGTQTKA EGPTIKNDAS
181 QQTNYGVAVL DKEIIQLSDY LKEALQRELV LKQKMVILQD LLSTLIQASD SSWKGQLNED
241 KLKGKLRSLE NQLYTCTQKY SPWGMKKVLL EMEDQKNSYE QKAKESLQKV LEEKMNAEQQ
301 LQSTQRSLAL AEQKCEEWRS QYEALKEDWR TLGTQHRELE SQLHVLQSKL QGADSRDLQM
361 NQALRFLENE HQQLQAKIEC LQGDRDLCSL DTQDLQDQLK RSEAEKLTLV TRVQQLQGLL
421 QNQSLQLQEQ EKLLTKKDQA LPVWSPKSFP NEVEPEGTGK EKDWDLRDQL QKKTLQLQAK
481 EKECRELHSE LDNLSDEYLS CLRKLQHCRE ELNQSQQLPP RRQCGRWLPV LMVVIAAALA
541 VFLANKDNLM ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAF3IP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 122 nTPM
Expression across tissuesHPA
Tissue
- thymus: 122 nTPM
- lymph node: 93 nTPM
- tonsil: 85 nTPM
- spleen: 57 nTPM
- appendix: 49 nTPM
- bone marrow: 30 nTPM
Single-cell type
- neutrophils: 326 nCPM
- t-cells: 180 nCPM
- nk-cells: 177 nCPM
- neutrophil progenitors: 153 nCPM
- endometrial luminal cells: 142 nCPM
- microglia: 138 nCPM
Immune cell
- T-reg: 589 nTPM
- naive CD4 T-cell: 461 nTPM
- basophil: 459 nTPM
- total PBMC: 415 nTPM
- memory CD4 T-cell: 412 nTPM
- naive CD8 T-cell: 366 nTPM
Brain region
- cerebral cortex: 9 nTPM
- white matter: 7.2 nTPM
- medulla oblongata: 5.8 nTPM
- thalamus: 5.7 nTPM
- pons: 5.6 nTPM
- midbrain: 4.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antiviral innate immune response
- cellular response to interferon-beta
- cytoplasmic pattern recognition receptor signaling pathway
- positive regulation of interferon-beta production
- positive regulation of type I interferon production
Molecular functions
- molecular adaptor activity
- protein-macromolecule adaptor activity
- zf-TRAF domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAF3IP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAF3IP3 as an antibody target. Whether an autoantibody or antibody against TRAF3IP3 could matter depends on whether native TRAF3IP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAF3IP3 is annotated at the cell surface, where native TRAF3IP3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRAF3IP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...